Presentation Developed by the French laboratory Revitacare, CytoCare 502 is an injectable mesotherapy solution designed specifically for young skin, generally between 25 and 35 years old. This preventive treatment helps maintain the skin's youthful capital by delaying the appearance of the first wrinkles and reviving the natural radiance of the complexion thanks to its hydrating and antioxidant properties.
Composition
& Rheology Non-cross-linked hyaluronic acid: 2 mg Rejuvenating complex rich in antioxidants Box containing 10 vials of 5 ml (total volume 50 ml)
Indications
This product is indicated for the prevention of skin aging. It primarily targets the face, neck, and the back of the hands. It helps smooth emerging fine lines, deeply hydrate the dermis, and protect the skin against environmental oxidative stress. Posology Administration should be performed in the superficial to medium dermis.
The protocol generally recommends spacing sessions by at least one week, using a maximum of one vial per treatment. The procedure can be performed with a fine needle or using a microneedling device (derma pen or derma roller). Regular maintenance sessions are advised to sustain the results.
Storage Store away from direct light, in a dry place at room temperature (between 2°C and 25°C). Do not freeze and verify the integrity of the packaging before use. Contraindications Minors Pregnant or breastfeeding women Patients with known hypersensitivity to hyaluronic acid or any of the components Presence of skin lesions or infections in the area to be treated
FAQ
At what age is it recommended to use CytoCare 502? It is ideally formulated for patients aged 25 to 35 as a prevention against the first signs of aging. Are the results immediate? Yes, an improvement in hydration and complexion luminosity is naturally visible from the first session.
